Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,975.1
50.5 (1.73%)

 

  • STI Straits Times Index
    2,975.1
    50.5 (1.73%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,584.0
    26.4 (1.70%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    30,074.2
    355.9 (1.20%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,585.0
    21.0 (0.59%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,671.7
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,289.6
    38.6 (0.62%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,531.1M
  • Value: 1,587.9M
  • Rise: 238
  • Fall: 113
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Thomson Medical0.116+0.007
Shen Yao0.004-
Oceanus^0.074+0.003
Secura0.099+0.013
Jiutian Chemical0.096-
Sembcorp Marine0.156+0.004
ThaiBev0.735+0.015
YZJ Shipbldg SGD1.060+0.020
ComfortDelGro1.620+0.030
SIA4.990+0.300

World Indices

World Indices
Name Last Change
Nasdaq 13,598.0 +132.8
HSI 30,074.2 +355.9
HSCEI 11,717.4 +207.7
Jakarta 6,289.6 +38.6
Nikkei 225 29,671.7
SSE Comp 3,585.0 +21.0
Shanghai A 3,758.0 +22.0
Shanghai B 245.9
KOSPI 3,099.7 +104.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BIO-TECHNE CORP BIO-TECHNE CORPORATION
Updated on 24 Feb 2021 (End of trading day)
Last (USD): 374.690 Change: -2.170 High: 379.860 Remarks: -
Change (%): -0.58 Low: 372.260
Open 375.790 Yesterday's Close 376.86
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 137,204 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 5.90410 Trailing EPS (USD) e 4.50442 NAV (USD) b 39.2259
PE a 63.463 Trailing PE f 83.183 Price / NAV b 9.5521
Dividend (USD) d 1.268593 Cash In Hand (USD) g 4.2663 Issued & Paid-up Shares c 38,798,800
Dividend Yield (%) d 0.339 Price / Cash In Hand g 87.826 Treasury Shares h -
Market Cap (M) 14,537.522 Enterprise Value (M) 14,568.627
Piotroski F Score 6 Exchange Code TECH Par Value ( $ ) n.a.
52 Weeks Volatility (%) 43.02 Free Float (%) 98.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BIO-TECHNE CORP NASDAQ 14,537.522 63.463 83.183 9.5521 0.339
Industry Biotechnology NASDAQ 3,074.950 1438.131 - 7.3575 0.578
Local Peer AMGEN INC NASDAQ 132,834.404 18.287 18.287 14.1178 2.786
Local Peer GILEAD SCIENCES INC NASDAQ 79,892.340 649.506 649.531 4.3846 4.269
Local Peer ILLUMINA INC NASDAQ 67,267.195 102.541 102.541 14.3305 -
Local Peer MODERNA INC NASDAQ 57,294.851 - - 20.7605 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,421.718 20.807 20.807 6.4951 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 49,130.721 13.985 13.985 4.4562 -
Local Peer BIOGEN INC NASDAQ 43,071.481 10.766 10.766 4.0253 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,964.318 56.288 56.288 2.9151 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 30,634.978 - - 7.1452 -
Local Peer SEAGEN INC NASDAQ 28,084.043 45.764 45.764 8.0514 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 27,192.211 - - 24.9962 -
Local Peer EXACT SCIENCES CORP NASDAQ 22,797.118 - - 8.0741 -
Other Local Peers 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), NANTKWEST INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SEER INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIELA BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), UNIQURE N.V. (NASDAQ), SHATTUCK LABS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), OMEROS CORP (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VAXCYTE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), EPIZYME INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INHIBRX INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), RADIUS HEALTH INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MERUS B V (NASDAQ), AGENUS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ATRECA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ARDELYX INC (NASDAQ), AFFIMED N V (NASDAQ), AKOUOS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADICET BIO INC (NASDAQ), BIOVIE INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVROBIO INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SESEN BIO INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ATHERSYS INC (NASDAQ), ONCORUS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), VERASTEM INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), IMMUNOME INC (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CABALETTA BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), METACRINE INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ORGENESIS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), INFLARX N V (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), LONGEVERON INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), SAVARA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), GEOVAX LABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 121,921.264 38.874 32.036 11.5375 1.095
Global Peer WUXI BIO HKEx 439,118.645 381.981 304.963 29.3960 -
Global Peer BEIGENE HKEx 236,406.996 - - 7.1147 -
Global Peer SINO BIOPHARM HKEx 164,621.039 53.635 64.329 4.5675 0.609
Global Peer ZAI LAB-SB HKEx 104,836.822 - - 29.0602 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,266.040 17.260 17.260 3.6393 -
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer GENSCRIPT BIO HKEx 28,616.048 - - 3.9138 -
Global Peer 3SBIO HKEx 20,882.956 18.914 13.908 1.7852 -
Global Peer JW THERAP-B HKEx 17,146.786 - - -16.9188 -
Other Global Peers NUVATION BIO INC (NYSE), JACOBIO-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), JHBP-B (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), TELIX PHARMACEUTIC (ASX), KINTOR PHARMA-B (HKEx), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), OPTHEA LIMITED (ASX), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), ANTEOTECH LIMITED (ASX), ESSEX BIO-TECH (HKEx), NANOVIRICIDES INC (NYSE American), BIONOMICS LTD (ASX), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), IBIO INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), CHIMERIC THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), CYNATA THERAPEUTICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), CT ENTERPRISE (HKEx), PATRYS LIMITED (ASX), BIOTRON (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ADALTA LTD (ASX), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --22.390
-5.64 %
10 Days 0.320-20.330
-5.07 %
20 Days 0.320+52.170
+16.27 %
Medium Term Return 3 Months 0.320+72.940
+24.28 %
6 Months 28.800+121.650
+59.46 %
1 Year 79.360+181.680
+135.25 %
Long Term Return 2 Years 80.640+180.790
+134.83 %
3 Years 81.920+233.860
+224.23 %
5 Years 84.480+283.690
+404.58 %
Annualised Return Annualised --
+38.22 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 155.170 - 414.990 Change From 1 Year Low +219.520 % Change From 1 Year Low (%) +141.47
Change From 1 Year High -40.300 % Change From 1 Year High (%) -9.71
2 Years Range 155.170 - 414.990 Change From 2 Years Low +219.520 % Change From 2 Years Low (%) +141.47
Change From 2 Years High -40.300 % Change From 2 Years High (%) -9.71
5 Years Range 87.655 - 414.990 Change From 5 Years Low +287.035 % Change From 5 Years Low (%) +327.46
Change From 5 Years High -40.300 % Change From 5 Years High (%) -9.71
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Protein Sciences and Diagnostics &Genomics. The Protein Sciences segment develops and manufactures purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. This segment also includes protein analysis solutions that offer researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics &Genomics segment develops and manufactures diagnostic products, including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. This segment also manufactures and sells advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use. The company was founded on 1976 and is headquartered in Minneapolis, MN.

Historical Price Data

Date Open High Low Close Volume VWAP
24 Feb 2021 375.790 379.860 372.260 374.690 137,204 -
23 Feb 2021 379.900 379.900 369.425 376.860 214,322 -
22 Feb 2021 388.010 389.000 375.790 377.000 191,573 -
19 Feb 2021 398.240 401.370 388.260 389.550 207,137 -
18 Feb 2021 407.020 407.020 395.330 397.080 137,595 -
17 Feb 2021 407.000 410.225 404.170 407.260 224,538 -
16 Feb 2021 401.940 414.990 401.280 411.000 310,556 -
12 Feb 2021 396.240 405.525 394.650 398.860 173,165 -
11 Feb 2021 391.400 396.300 387.000 395.020 152,792 -
10 Feb 2021 392.910 395.427 385.510 390.300 113,557 -
09 Feb 2021 392.880 396.000 385.300 389.950 144,029 -
08 Feb 2021 385.000 391.380 382.190 390.570 368,770 -
05 Feb 2021 387.090 388.560 377.100 380.670 201,247 -
04 Feb 2021 370.000 384.960 368.930 382.730 198,763 -
03 Feb 2021 379.040 379.040 360.960 368.410 230,023 -
02 Feb 2021 357.950 399.830 357.950 376.760 521,637 -
01 Feb 2021 330.180 341.790 328.200 340.070 185,765 -
29 Jan 2021 324.450 329.470 322.000 324.910 218,012 -
28 Jan 2021 321.160 324.720 311.030 322.520 294,810 -
27 Jan 2021 336.370 336.600 317.690 318.430 194,366 -
26 Jan 2021 354.200 356.635 339.850 340.340 97,911 -
25 Jan 2021 358.900 361.170 350.890 352.440 130,401 -
Summary
Current 2 Weeks
(10 Feb 2021 to 24 Feb 2021)
392.910 414.990 369.425 374.690 1,862,439 -
Previous 2 Weeks
(27 Jan 2021 to 09 Feb 2021)
336.370 414.990 317.690 389.950 2,557,422 -
4 Weeks from
(28 Dec 2020 to 26 Jan 2021)
324.350 414.990 314.530 340.340 2,934,730 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.